Plant ID: NPO13637
Plant Latin Name: Thalictrum foliolosum
Taxonomy Genus: Thalictrum
Taxonomy Family: Ranunculaceae
NCBI TaxonomyDB:
1277777
Plant-of-the-World-Online:
714441-1
Antiperiodic; Diuretic; Febrifuge; Ophthalmic; Purgative; Salve; Stomachic; Tonic
India; Nepal; China; Myanmar; Thailand
GAA; | |
USP2; | |
SMN1;SMN2; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 5.826E-10 | 1.269E-05 | CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 1.736E-07 | 1.890E-03 | CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 3.377E-07 | 2.237E-03 | CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 4.108E-07 | 2.237E-03 | CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 6.888E-06 | 1.468E-02 | CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 7.417E-06 | 1.468E-02 | CYP2C19, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 7.417E-06 | 1.468E-02 | CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 9.757E-06 | 1.634E-02 | CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.905E-05 | 2.593E-02 | CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 2.838E-05 | 3.635E-02 | CYP2D6, CYP3A4 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 8.975E-04 | 4.343E-01 | CYP2C19, CYP2D6, CYP3A4, GAA, LMNA |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 3.273E-03 | 9.137E-01 | CYP2C19, CYP2D6, CYP3A4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.362E-06 | 2.452E-05 | CYP2D6, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 4.244E-05 | 3.820E-04 | CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 2.727E-04 | 1.548E-03 | CYP2D6, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 6.408E-04 | 2.307E-03 | CYP2D6, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 3.441E-04 | 1.548E-03 | CYP3A4, CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 6.873E-03 | 2.062E-02 | GAA, CYP2C19, CYP3A4 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00500 | Starch and sucrose metabolism | 1.944E-02 | 3.294E-02 | GAA |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.599E-02 | 3.294E-02 | CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 2.150E-02 | 3.294E-02 | CYP2C19 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 1.045E-02 | 2.688E-02 | GAA |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |